LumiThera® Light Therapy for Retinal Health

Advanced Photobiomodulation Treatment Now Offered by Dr. Srouji at Oklahoma Retina

At Oklahoma Retina, Dr. Srouji is proud to offer the latest in non-invasive treatment options for retinal disease—including LumiThera® photobiomodulation (PBM) therapy. This innovative light-based therapy is FDA-cleared for improving visual function in patients with dry age-related macular degeneration (AMD) and is supported by years of clinical research.

LumiThera’s approach uses targeted multi-wavelength light therapy to stimulate cellular activity, reduce inflammation, and support the eye’s natural healing process. As a retina specialist, Dr. Srouji offers this advanced treatment to patients seeking cutting-edge solutions for managing progressive vision loss.

lumithera
lumithera
lumithera doctor oklahoma

What Is LumiThera®?

LumiThera is a medical technology company specializing in photobiomodulation therapy for ocular health. Their flagship device, the Valeda® Light Delivery System, delivers specific wavelengths of light to the retina, promoting cellular energy production and helping to preserve visual function.

This non-invasive treatment is especially beneficial for early to intermediate stages of dry AMD, a condition that affects millions of Americans and currently has few treatment options. LumiThera’s PBM therapy is safe, painless, and performed in-office.

Benefits of LumiThera® Photobiomodulation (PBM) Therapy for Macular Degeneration:

  • Non-invasive and drug-free – No injections, incisions, or pharmaceuticals required.

  • Clinically proven to improve visual acuity – Demonstrated improvements in contrast sensitivity and vision clarity.

  • Helps preserve retinal health in dry AMD – Targets cellular dysfunction to support long-term eye health.

  • Painless with no downtime – Quick, comfortable in-office treatment sessions with no recovery period.

  • Backed by peer-reviewed clinical studies – Supported by published data from international research trials.

  • Enhances mitochondrial function – Boosts cellular energy (ATP) production to improve retinal cell performance.

  • Safe and well-tolerated – Low-level light therapy does not damage tissue or cause thermal effects.

  • May slow disease progression – Designed to intervene early in the disease process before significant vision loss occurs.

Is LumiThera Right for You?

If you’ve been diagnosed with dry macular degeneration, LumiThera may be a promising addition to your personalized treatment plan. Dr. Srouji will conduct a comprehensive retinal evaluation to determine whether photobiomodulation is appropriate for your condition.

This therapy is ideal for patients in the early stages of dry AMD who want to take proactive steps toward preserving vision. LumiThera is not a cure, but it can help slow progression and improve functional outcomes.

lumithera doctor oklahoma

Valeda® Light Delivery System for Dry Age-Related Macular Degeneration (AMD)

At Oklahoma Retina, we are proud to offer the Valeda® Light Delivery System—the first and only FDA-approved treatment designed to improve vision in patients with dry age-related macular degeneration (AMD).

Valeda uses photobiomodulation (PBM), a safe and non-invasive light therapy that works at the cellular level. By delivering specific wavelengths of low-intensity light, this advanced system targets the underlying cellular dysfunction of dry AMD, enhancing mitochondrial activity and promoting better energy (ATP) production within the eye’s cells.

Unlike surgical lasers that generate heat or cause tissue damage, PBM uses gentle, low-level light that does not harm surrounding tissue—making it a safe and effective option for managing dry AMD.

Photobiomodulation (PBM) is an emerging treatment approach in ophthalmology that shows significant promise for macular degeneration. By using specific wavelengths of light to stimulate cellular activity, PBM targets the underlying cellular dysfunction associated with dry age-related macular degeneration (AMD). This innovative therapy is designed to enhance mitochondrial function and support healthier retinal cells, offering a non-invasive option to improve visual outcomes and potentially slow the progression of the disease.

To learn more about how Valeda treatment for dry AMD may help preserve and improve your vision, contact Oklahoma Retina today.

Why Choose Oklahoma Retina?

At Oklahoma Retina, we are committed to providing our patients with the most advanced retinal treatments available.

Dr. Srouji combines compassionate care with leading-edge technologies like LumiThera to help patients manage vision-threatening conditions with confidence.

When you visit our clinic, you’ll receive a thorough consultation, clear answers, and a personalized care plan built around the latest science in ocular health.

Contact Us to Schedule an Appointment.

Dr Nabil Srouji - Oklahoma Retina

Schedule a Consultation

Take control of your vision today. If you or a loved one has dry macular degeneration and would like to learn more about LumiThera light therapy, contact Oklahoma Retina to schedule an appointment with Dr. Srouji.

Serving patients across Oklahoma at our new office in Oklahoma City.
Oklahoma Retina
3520 NW 58th St Suite A-100
Oklahoma City, Oklahoma 73112

 (405) 443-3350